IMRX:NASDAQ
Immuneering Corp
၄.၁၉ US$
၀.၀၀%
(၀.၀၀) 1D
၄.၁၉ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: ဇွန် ၁၅, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMRX...
Open
၄.၂၇ US$
High
၄.၃၂ US$
Low
၄.၁၃ US$
Mkt. cap
၂၇.၁၁ ကုဋေ
Avg. vol.
၁.၈၃ သန်း
Volume
၉.၀၀ သိန်း
52-wk high
၁၀.၀၈ US$
52-wk low
၁.၆၇ US$
EPS
-၁.၁၇ US$
Beta
၀.၃၈
Shares outstanding
၆.၄၇ ကုဋေ
No. of employees
၅၅
Open
၄.၂၇ US$
High
၄.၃၂ US$
Low
၄.၁၃ US$
Mkt. cap
၂၇.၁၁ ကုဋေ
Avg. vol.
၁.၈၃ သန်း
Volume
၉.၀၀ သိန်း
52-wk high
၁၀.၀၈ US$
52-wk low
၁.၆၇ US$
EPS
-၁.၁၇ US$
Beta
၀.၃၈
Shares outstanding
၆.၄၇ ကုဋေ
No. of employees
၅၅
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to IMRX in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current ၄.၁၉ US$
၂၀.၀၀ US$ (+၃၇၇.၃၃%)
Average
၁၃.၇၅ US$ (+၂၂၈.၁၆%)
Lowest
၁၁.၀၀ US$ (+၁၆၂.၅၃%)
News stories
From sources across the web
www.marketscreener.com
·
ပြီးခဲ့သည့် ၇ နာရီ
Immuneering Corporation Announces Appointment of Andrew Gengos to Chief Financial Officer, Effective July 16, 2026
Investing.com
·
ပြီးခဲ့သည့် ၈ နာရီ
Immuneering names Andrew Gengos as chief financial officer
The Manila Times
·
ပြီးခဲ့သည့် ၉ နာရီ
Immuneering Appoints Andrew Gengos as Chief Financial Officer
newsline.com
·
ပြီးခဲ့သည့် ၁ ရက်
IMRX Q1 2026 Earnings: EPS Surprises to the Upside Amid Continued Clinical Progress - Tech Earnings Analysis
About Immuneering Corp
AI content may include mistakes. Learn more